Browse the complete list of publications for PLCO.
Filter results of publications table below
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis. | 35113855 | Yarmolinsky J, Díez-Obrero V, Richardson TG, Pigeyre M, Sjaarda J, Paré G, Walker VM, Vincent EE, Tan VY, Obón-Santacana M, Albanes D, Hampe J, Gsur A, Hampel H, Pai RK, Jenkins M, Gallinger S, Casey G, Zheng W, Amos CI, International Lung Cancer Co… | PLoS Med | 2022 | PLCO |
| Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis. | 35048991 | Murphy N, Song M, Papadimitriou N, Carreras-Torres R, Langenberg C, Martin RM, Tsilidis KK, Barroso I, Chen J, Frayling TM, Bull CJ, Vincent EE, Cotterchio M, Gruber SB, Pai RK, Newcomb PA, Perez-Cornago A, van Duijnhoven FJB, Van Guelpen B, Vodicka… | J Natl Cancer Inst | 2022 | PLCO |
| Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials. | 35351104 | Gelfond JA, Hernandez B, Goros M, Ibrahim JG, Chen MH, Sun W, Leach RJ, Kattan MW, Thompson IM, Ankerst DP, Liss M | BMC Urol | 2022 | PLCO |
| IPRS: Leveraging Gene-Environment Interaction to Reconstruct Polygenic Risk Score. | 35401709 | Tang Y, You D, Yi H, Yang S, Zhao Y | Front Genet | 2022 | PLCO |
| Body mass index and risk of progression from monoclonal gammopathy of undetermined significance to multiple myeloma: Results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. | 35365600 | Chang VC, Khan AA, Huang WY, Katki HA, Purdue MP, Landgren O, Hofmann JN | Blood Cancer J | 2022 | PLCO |
| Alu Retroelement Copy Number and Lung Cancer Risk in the Prospective Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. | 35609672 | Wong JYY , Cawthon R , Hu W , Ezennia S , Gadalla SM , Breeze C , Blechter B , Freedman ND , Huang WY , Hosgood HD , Seow WJ , Bassig BA , Rahman ML , Hayes RB , Rothman N , Lan Q | Chest | 2022 | PLCO |
| Prospective Associations of Circulating Bile Acids and Short-Chain Fatty Acids With Incident Colorectal Cancer. | 35583137 | Loftfield E, Falk RT, Sampson JN, Huang WY, Hullings A, Murphy G, Weinstein SJ, Albanes D, Freedman ND, Sinha R | JNCI Cancer Spectr | 2022 | PLCO |
| Association Between Diabetes Risk Reduction Diet and Lung Cancer Risk in 98,159 Participants: Results From a Prospective Study. | 35574372 | Zhang Y, Zhong G, Zhu M, Chen L, Wan H, Luo F | Front Oncol | 2022 | PLCO |
| Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study Using the PLCO Cancer Screening Trial Data. | 35534235 | In H, Sarkar S, Ward J, Friedmann P, Parides M, Yang J, Epplein M | Cancer Epidemiol Biomarkers Prev | 2022 | PLCO |
| Genetic variants in DDO and PEX5L in peroxisome-related pathways predict non-small cell lung cancer survival. | 35502931 | Chen AS, Liu H, Wu Y, Luo S, Patz EF, Glass C, Su L, Du M, Christiani DC, Wei Q | Mol Carcinog | 2022 | PLCO |
| The Intervention Probability Curve: Modeling the Practical Application of Threshold-Guided Decision-Making, Evaluated in Lung, Prostate, and Ovarian Cancers. | 35732292 | Kammer MN, Rowe DJ, Deppen SA, Grogan EL, Kaizer AM, Barón AE, Maldonado F | Cancer Epidemiol Biomarkers Prev | 2022 | NLST, PLCO |
| Sweetened beverage consumption and risk of liver cancer by diabetes status: A pooled analysis. | 35728406 | Jones GS, Graubard BI, Ramirez Y, Liao LM, Huang WY, Alvarez CS, Yang W, Zhang X, Petrick JL, McGlynn KA | Cancer Epidemiol | 2022 | PLCO |
| Associations of genetic risk, BMI trajectories, and the risk of non-small cell lung cancer: a population-based cohort study. | 35658861 | You D, Wang D, Wu Y, Chen X, Shao F, Wei Y, Zhang R, Lange T, Ma H, Xu H, Hu Z, Christiani DC, Shen H, Chen F, Zhao Y | BMC Med | 2022 | PLCO |
| Impact of Comorbidities on Lung Cancer Screening Evaluation. | 35641376 | Robinson EM, Liu BY, Sigel K, Yin C, Wisnivesky J, Kale MS | Clin Lung Cancer | 2022 | PLCO |
| PLCOjs, a FAIR GWAS web SDK for the NCI Prostate, Lung, Colorectal and Ovarian Cancer Genetic Atlas project. | 35900159 | Ruan E , Nemeth E , Moffitt R , Sandoval L , Machiela MJ , Freedman ND , Huang WY , Wong W , Chen KL , Park B , Jiang K , Hicks B , Liu J , Russ D , Minasian L , Pinsky P , Chanock SJ , Garcia-Closas M , Almeida JS | Bioinformatics | 2022 | PLCO |
| Associations between dietary fiber intake and mortality from all causes, cardiovascular disease and cancer: a prospective study. | 35918724 | Xu X, Zhang J, Zhang Y, Qi H, Wang P | J Transl Med | 2022 | PLCO |
| Development and validation of a life expectancy calculator for US patients with prostate cancer. | 35373440 | Chase EC, Bryant AK, Sun Y, Jackson WC, Spratt DE, Dess RT, Schipper MJ | BJU Int | 2022 | PLCO |
| Independent and joint associations of weightlifting and aerobic activity with all-cause, cardiovascular disease and cancer mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. | 36167669 | Gorzelitz J, Trabert B, Katki HA, Moore SC, Watts EL, Matthews CE | Br J Sports Med | 2022 | PLCO |
| Prediagnostic BMI trajectories in relation to pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. | 36156459 | Hoyt M, Song Y, Gao S, O'Palka J, Zhang J | Obesity (Silver Spring) | 2022 | PLCO |
| Body mass index and glioma risk: A prospective multicenter study. | 36105407 | Shao C, Tang H, Wang X, He J, Wang P, Wu N | Front Endocrinol (Lausanne) | 2022 | PLCO |